Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

NCT00002520 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 434

Last updated 2023-06-15

No results posted yet for this study

Summary

RATIONALE: Physician-initiated smoking cessation strategies may be effective in getting early-stage cancer patients to quit smoking.

PURPOSE: Randomized clinical trial to compare the effectiveness of a physician-initiated stop-smoking program with the usual care for patients receiving treatment for early-stage cancer.

Conditions

Interventions

DRUG

nicotine

BEHAVIORAL

Usual Care

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Eastern Cooperative Oncology Group

    lead NETWORK

Principal Investigators

  • Paul F. Engstrom, MD · Fox Chase Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1990-12-07
Primary Completion
2002-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002520 on ClinicalTrials.gov